Number of person-tests of HLA-B*15∶02 screening compared to mammography and Pap smear.

1Overall SJS/TEN mortality rate ranged from 5% to 30%.2Based on the recommended biennial screening for 20 years from aged 50 years and detection of one case per 715 persons screened over this period. [25] Number excluded 20% non-compliance rate that was assumed in the original report.3Based on the recommended quinquennial screening for 35 years from aged 24 years and detection of one case per 1000 persons screened over this period. [26].